Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Decci who wrote (8308)	3/1/1998 11:42:00 PM
From: Greg Jenkins	Read Replies (1) \| Respond to of 14328

Greetings: Off topic: got a new monitor for computer. Sony 14"viewable trinitron, model 100ES, Digital multiscan (VGA 640X480), VESA 1024x768/85Hz, 1280x1024/60Hz. I don't know what it all means, but I consider Sony one of the better brands out there so I bought it. Now to get the video card. There are so many. Choices, choices, choices. ----------------------------------------------------------------------------------------------------------- On topic: Things are looking up. Bring on those earnings so we can announce the winner!! I am thinking of ways to increase our stock value and will report later. Greg P.S. Off topic again. Does anyone have an opinion or information on "Dave and Buster's" Nasdaq DANB. Looks interesting.

To: Decci who wrote (8308)	3/2/1998 4:39:00 PM
From: Caroline and Daughters	Respond to of 14328

You are right. On all counts. Our daughter who lives in Raleigh and is in the medical field tells me that the h.pylori test should be a money maker because to detrmine if a guy has h. pylori he must be put out and a biopsy taken, i.e. very expensive and HMOs would push this test real hard. How about women with h. pylori? We just ignore their complaints. Not much money in the Rotavirus she says. I love your metaphor of the headwaters of the mighty Mississipi. Not being a native born where are dem headwaters aren't they in North Dakota someplace? Now ask me about the headwaters of the Nile and I can tell you that they named the lake after my mother (Victoria) God alone knows what is called now probably Lake Umbakazoli or some such thing. Keeping my fingers crossed Triby SHOULD be in the teems soon. Keep in touch Grunt

To: Decci who wrote (8308)	3/2/1998 10:06:00 PM
From: Keiko	Respond to of 14328

* TB AND HIV TESTS "If we are able to get HIV tests in the field, that could be enormously helpful in terms of the impact on treatment," Davidson says. " I'm not one who believes that treatable conditions, even if they're not curable, are best left unknown. I think the sooner we can find HIV in out patients, the better." About 2 % of patients in TB Clinics could be expected to test positive for HIV. That estimate is based on data from the pool of people, many of whom are at high risk for HIV, who took HIV tests in 1996, the latest year for which figures are available. Implications for TB treatment are substantial, says Davidson. Current CDC recommendations say adult contacts of TB cases who are HIV positive , including contacts who are skin test positive and very close contacts should get 12 months of isoniazid prophylactic treatment IPT) not the conventional six months. In most instances, health departments expect no more than "a tenuous hold " as Davidson puts it , over people getting IPT. But with co-infected patients, health departments which have the resources to do so usually clamp down much harder by for example. providing directly observed preventive therapy for such patients, says Davidson. Plus, cases of active TB can be much harder to detect among co-infected populations than among HIV -negative populations. Treatment for people with active TB who are HIV infected or who have AIDS may also need to be altered in various ways. Even before the Health Service broke the news of it's turn-about, TB control experts had been sniffing the wind for news on alternative to conventional HIV testing. Recently, Davidson polled NTCA members to learn who was using rapid or non-invasive tests. TB controllers in Washington , DC, replied that they'd been getting an enthusiastic response to Epitope's OraSure test, a non-invasive assay that uses cheek fluid called oral mucosal transudate.Since last June, "all cases, suspects, and contacts have been offered the choice of the Orasure test or the regular test says Dr Kurt Brandt, TB controller in the nations capital. ~~~~ more later ~~~~~